Exuma Biotech grabs $19m Series B
West Palm Beach, Florida-based Exuma Biotech, a clinical-stage biotechnology company discovering and developing CAR-T therapies for solid and liquid tumors, has raised $19 million in Series B financing.
West Palm Beach, Florida-based Exuma Biotech, a clinical-stage biotechnology company discovering and developing CAR-T therapies for solid and liquid tumors, has raised $19 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
